Reproxalap API Manufacturers
compare suppliers & get competitive offers
Join our notification list by following this page.
Click the button below to find out more
Click the button below to switch over to the contract services area of Pharmaoffer.
Looking for Reproxalap API 916056-79-6?
- Description:
- Here you will find a list of producers, manufacturers and distributors of Reproxalap. You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
- API | Excipient name:
- Reproxalap
- Synonyms:
- ADX 102 , ADX102 , ALD-102 , NS-2 , Reproxalap
- Cas Number:
- 916056-79-6
- DrugBank number:
- DB16688
- Unique Ingredient Identifier:
- F0GIZ22IJH
General Description:
Reproxalap, identified by CAS number 916056-79-6, is a notable compound with significant therapeutic applications. Reproxalap (previously ADX 102 or NS-2) is a small molecule inhibitor being developed by Aldeyra Therapeutics investigated against dry eye disease, allergic conjunctivitis, noninfectious anterior uveitis, and Sjögren-Larsson syndrome. NS-2 has orphan drug status due to it being investigated for treatment of Sjogren-Larsson syndrome.
Mechanism of Action:
Reproxalap functions by: Reproxalap inhibits Reactive Aldehyde Species (RASP) and is being investigated against dry eye disease, allergic conjunctivitis, noninfectious anterior uveitis, and Sjögren-Larsson syndrome. This mechanism highlights the drug's role in inhibiting or promoting specific biological pathways, contributing to its therapeutic effects.
Categories:
Reproxalap is categorized under the following therapeutic classes: Heterocyclic Compounds, Fused-Ring, Quinolines. These classifications highlight the drug's diverse therapeutic applications and its importance in treating various conditions.
